SCHEMBL18177915

SCHEMBL18177915

CN1CCN(C23CC4CC(CC(C4)C2)C3)CC1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.47
HSD11B1 P28845 1/20 0.47
EPHX2 P34913 1/20 0.43
ALDH1A1 P00352 2/20 0.42
TSHR P16473 1/20 0.42
ATM Q13315 1/20 0.41
KDM4E B2RXH2 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
SCN1A P35498 1/20 0.37
SCN2A Q99250 1/20 0.37
SCN3A Q9NY46 1/20 0.37
TP53 P04637 1/20 0.36
POLB P06746 1/20 0.36
SIGMAR1 Q99720 1/20 0.35
GAA P10253 1/20 0.35
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24720249 0.90 HTT (0.36) HTTHSD11B1EPHX2ALDH1A1TSHR
SCHEMBL15922897 0.87 TP53 (0.41) HSD11B1ALDH1A1TSHRATMKDM4E
SCHEMBL16307931 0.86 HTT (0.40) HTTHSD11B1EPHX2ALDH1A1TSHR
SCHEMBL20032903 0.86 HTT (0.40) HTTHSD11B1EPHX2ALDH1A1TSHR
SCHEMBL1143530 0.80 TP53 (0.41) HSD11B1ALDH1A1TSHRATMTDP1
SCHEMBL455945 0.77 TP53 (0.36) EPHX2ALDH1A1TSHRATMKDM4E
SCHEMBL11355878 0.77 HSD11B1 (0.41) HSD11B1TSHRATMTDP1TP53
SCHEMBL15922741 0.77 TP53 (0.39) HSD11B1TSHRATMTDP1TP53
SCHEMBL19073248 0.76 TP53 (0.36) ALDH1A1TSHRATMTP53POLB
SCHEMBL13028775 0.76 ALDH1A1 (0.37) ALDH1A1TSHRATMTP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200071735-A1 Compounds for Increasing Lipid Synthesis and Storage WASE, NISHIKANT 2020-03-05 US disclosed
US-10351883-B2 Compounds for increasing lipid synthesis and storage NUTECH VENTURES (US) 2019-07-16 US disclosed
US-20160312253-A1 Compounds for Increasing Lipid Synthesis and Storage INVITROGEN CORPORATION 2016-10-27 US disclosed
US-20160312253-A1 Compounds for Increasing Lipid Synthesis and Storage INVITROGEN CORPORATION 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160312253-A1 Compounds for Increasing Lipid Synthesis and Storage FASN, LIPC, SREBF2 HTT 3738/4885HSD11B1 615/4885EPHX2 1507/4885
US-10351883-B2 Compounds for increasing lipid synthesis and storage FASN, LIPC, SREBF2 HTT 3738/4885HSD11B1 615/4885EPHX2 1507/4885
US-20200071735-A1 Compounds for Increasing Lipid Synthesis and Storage FASN, LIPC, SREBF2 HTT 3738/4885HSD11B1 615/4885EPHX2 1507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.